Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting
Blake M. Hauser, Maya Sangesland, Kerri St. Denis, et al.
Cell Reports (2022) Vol. 38, Iss. 12, pp. 110561-110561
Open Access | Times Cited: 25

Showing 25 citing articles:

Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responses
Jeroen M. J. Tas, Jahyun Koo, Ying‐Cing Lin, et al.
Immunity (2022) Vol. 55, Iss. 10, pp. 1856-1871.e6
Open Access | Times Cited: 99
Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds
Eike‐Christian Wamhoff, Larance Ronsard, Jared Feldman, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 40
Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses
Wanting He, Rami Musharrafieh, Ge Song, et al.
Nature Immunology (2022) Vol. 23, Iss. 6, pp. 960-970
Open Access | Times Cited: 56
A human antibody epitope map of Pfs230D1 derived from analysis of individuals vaccinated with a malaria transmission-blocking vaccine
Wai Kwan Tang, Camila H. Coelho, Kazutoyo Miura, et al.
Immunity (2023) Vol. 56, Iss. 2, pp. 433-443.e5
Open Access | Times Cited: 27
Rethinking Optimal Immunogens to Face SARS‐CoV‐2 Evolution Through Vaccination
Julià Blanco, Benjamin Trinité, Joan Puig‐Barberà
Influenza and Other Respiratory Viruses (2025) Vol. 19, Iss. 1
Open Access
Pan‐Variant SARS‐CoV‐2 Vaccines Induce Protective Immunity by Targeting Conserved Epitopes
Masaud Shah, Sung Ung Moon, Ji‐Yon Shin, et al.
Advanced Science (2025)
Open Access
Epistasis between N-terminal and receptor-binding domains drives cell entry in a bat coronavirus spike
Alexandra L. Tse, Cory M. Acreman, Inna Ricardo-Lax, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds
Eike‐Christian Wamhoff, Larance Ronsard, Jared Feldman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 17
Mosaic RBD nanoparticle elicits immunodominant antibody responses across sarbecoviruses
Chuanyu Liu, Senyu Xu, Yuxuan Zheng, et al.
Cell Reports (2024) Vol. 43, Iss. 5, pp. 114235-114235
Open Access | Times Cited: 2
Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies
William O. Hahn, K. Rachael Parks, Mingchao Shen, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 10
Closed Access | Times Cited: 2
Adaptation‐Proof SARS‐CoV‐2 Vaccine Design
Yashavantha L. Vishweshwaraiah, Brianna Hnath, Brendan Rackley, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 49
Open Access | Times Cited: 12
Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice
Etsuro Nanishi, Francesco Borriello, Hyuk‐Soo Seo, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 7
CryoVirusDB: A Labeled Cryo-EM Image Dataset for AI-Driven Virus Particle Picking
Rajan Gyawali, Ashwin Dhakal, Liguo Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
HIV BG505 SOSIP.664 trimer with 3M-052-AF/alum induces human autologous tier-2 neutralizing antibodies
William O. Hahn, K. Rachael Parks, Mingchao Shen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Engineering a SARS-CoV-2 Vaccine Targeting the Receptor-Binding Domain Cryptic-Face via Immunofocusing
Theodora U. J. Bruun, Jonathan Do, Payton A. Weidenbacher, et al.
ACS Central Science (2024) Vol. 10, Iss. 10, pp. 1871-1884
Open Access | Times Cited: 1
Distinct pathways for evolution of enhanced receptor binding and cell entry in SARS-like bat coronaviruses
Alexandra L. Tse, Cory M. Acreman, Inna Ricardo-Lax, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 11, pp. e1012704-e1012704
Open Access | Times Cited: 1
Cross-reactive SARS-CoV-2 epitope targeted across donors informs immunogen design
Blake M. Hauser, Jared Feldman, Maya Sangesland, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 12, pp. 100834-100834
Open Access | Times Cited: 7
Antigenic Site Immunodominance Redirection Following Repeat Variant Exposure
Lisa C. Lindesmith, Paul D. Brewer-Jensen, Michael L. Mallory, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1293-1293
Open Access | Times Cited: 6
Heterologous Sarbecovirus Receptor Binding Domains as Scaffolds for SARS-CoV-2 Receptor Binding Motif Presentation
Blake M. Hauser, Maya Sangesland, Evan C. Lam, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 2, pp. 553-561
Open Access
Engineering a SARS-CoV-2 vaccine targeting the RBD cryptic-face via immunofocusing
Theodora U. J. Bruun, Jonathan Do, Payton A. Weidenbacher, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Glycan masking of NTD loops with a chimeric RBD of the spike protein as a vaccine design strategy against emerging SARS‐CoV‐2 Omicron variants
Hao‐Chan Hung, Boon‐Fatt Tan, Wei‐Shuo Lin, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 9
Open Access
Adaptation-proof SARS-CoV-2 vaccine design
Yashavantha L. Vishweshwaraiah, Brianna Hnath, Brendan Rackley, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Antibodies as drugs—a Keystone Symposia report
Jennifer Cable, Erica Ollmann Saphire, Adrian Hayday, et al.
Annals of the New York Academy of Sciences (2022) Vol. 1519, Iss. 1, pp. 153-166
Open Access | Times Cited: 3
Humoral responses to the SARS-CoV-2 spike and receptor binding domain in context of pre-existing immunity confer broad sarbecovirus neutralization
Blake M. Hauser, Maya Sangesland, Evan C. Lam, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 2
High-Affinity Antibodies Designing of SARS-CoV-2 Based on Molecular Dynamics Simulations
Zihui Tian, Hongtao Liu, Shuangyan Zhou, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 481-481
Open Access | Times Cited: 1
Page 1

Scroll to top